Health | Fortune

Skip to Content

NEW

A vastly improved search engine helps you find the latest on companies, business leaders, and news more easily.

SIGN IN

International
England’s reopening is officially in limbo, serving up a cautionary tale for countries on the vaccination forefront
By
Sophie Mellor
June 14, 2021
Health
Novavax COVID-19 vaccine is about 90% effective, according to late-stage study
By
The Associated Press
and
Linda Johnson
June 14, 2021
Newsletters
The basic inequity in the tax system is hard to swallow
By
Alan Murray
and
David Meyer
June 14, 2021
Commentary
To vaccinate our economy, boost support for the NIH
By
Gary K. Michelson
June 13, 2021
Health
What we know about COVID vaccines, heart inflammation, and its implications for drug makers
By
Sy Mukherjee
June 11, 2021
Health
As the vaccine surplus grows in the U.S., states are struggling to administer doses before expiration date
By
Lindsay Whitehurst
and
The Associated Press
June 11, 2021
Newsletters
British regulators will shape Google’s future, as antitrust watchdog reveals Privacy Sandbox deal
By
David Meyer
June 11, 2021
Newsletters
What comes next after the Biogen Alzheimer’s drug approval
By
Sy Mukherjee
June 10, 2021
Newsletters
Climate, inflation and COVID-19: Highlights from Day Two of the Fortune Global Forum
By
Alan Murray
and
David Meyer
June 10, 2021
Health
Pressure grows to drop COVID-19 vaccine patent protections as European lawmakers back waiver
By
David Meyer
June 10, 2021
International
India needs Pfizer vaccines—but company demand for legal protection is holding things up
By
Biman Mukherji
June 10, 2021
Health
12% of the world’s population has received a COVID vaccine. See how your country is doing
By
Erika Fry
and
Nicolas Rapp
June 10, 2021
Environment
Zoos are filling up again. Are the animals safe?
By
Jessica Mathews
June 9, 2021
Health
Biogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?
By
Sy Mukherjee
June 9, 2021

1 - 14 of 7,027 results

1 - 14 of 7,027 results

© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Personal Information | Ad Choices
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.